Marathon Asset Management LLP Has $113.67 Million Stake in Waters Co. (WAT)

Marathon Asset Management LLP reduced its stake in shares of Waters Co. (NYSE:WAT) by 11.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 588,384 shares of the medical instruments supplier’s stock after selling 76,365 shares during the period. Waters accounts for 1.8% of Marathon Asset Management LLP’s portfolio, making the stock its 19th biggest holding. Marathon Asset Management LLP’s holdings in Waters were worth $113,674,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds also recently bought and sold shares of the company. National Pension Service lifted its position in shares of Waters by 0.3% during the 4th quarter. National Pension Service now owns 84,896 shares of the medical instruments supplier’s stock valued at $16,401,000 after buying an additional 275 shares in the last quarter. Bank of Montreal Can lifted its position in shares of Waters by 17.6% during the 4th quarter. Bank of Montreal Can now owns 81,050 shares of the medical instruments supplier’s stock valued at $15,657,000 after buying an additional 12,109 shares in the last quarter. Nisa Investment Advisors LLC lifted its position in shares of Waters by 0.5% during the 4th quarter. Nisa Investment Advisors LLC now owns 46,545 shares of the medical instruments supplier’s stock valued at $8,992,000 after buying an additional 253 shares in the last quarter. Progressive Investment Management Corp lifted its position in shares of Waters by 1.3% during the 4th quarter. Progressive Investment Management Corp now owns 22,606 shares of the medical instruments supplier’s stock valued at $4,367,000 after buying an additional 285 shares in the last quarter. Finally, Copper Rock Capital Partners LLC lifted its position in shares of Waters by 47.2% during the 4th quarter. Copper Rock Capital Partners LLC now owns 50,367 shares of the medical instruments supplier’s stock valued at $9,812,000 after buying an additional 16,153 shares in the last quarter. 92.13% of the stock is currently owned by hedge funds and other institutional investors.

Shares of Waters Co. (NYSE WAT) traded down $0.81 on Wednesday, reaching $208.94. The company had a trading volume of 512,100 shares, compared to its average volume of 361,970. The company has a market cap of $16,682.05, a P/E ratio of 30.82, a PEG ratio of 2.81 and a beta of 0.82. Waters Co. has a 52 week low of $137.72 and a 52 week high of $211.65. The company has a debt-to-equity ratio of 0.66, a current ratio of 6.16 and a quick ratio of 5.71.

Waters (NYSE:WAT) last released its quarterly earnings data on Tuesday, October 24th. The medical instruments supplier reported $1.77 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.74 by $0.03. Waters had a return on equity of 23.61% and a net margin of 24.34%. The business had revenue of $565.58 million for the quarter, compared to the consensus estimate of $555.25 million. During the same quarter in the previous year, the company posted $1.57 EPS. The company’s revenue was up 7.4% compared to the same quarter last year. equities research analysts predict that Waters Co. will post 7.42 EPS for the current year.

In other Waters news, SVP Rohit Khanna sold 26,913 shares of Waters stock in a transaction that occurred on Friday, October 27th. The stock was sold at an average price of $197.93, for a total value of $5,326,890.09. Following the sale, the senior vice president now owns 13,677 shares of the company’s stock, valued at approximately $2,707,088.61. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Joann A. Reed sold 1,386 shares of Waters stock in a transaction that occurred on Tuesday, January 2nd. The stock was sold at an average price of $194.07, for a total value of $268,981.02. The disclosure for this sale can be found here. In the last ninety days, insiders sold 93,159 shares of company stock worth $18,412,172. Corporate insiders own 5.07% of the company’s stock.

Several analysts recently issued reports on the company. Zacks Investment Research raised Waters from a “hold” rating to a “buy” rating and set a $211.00 target price on the stock in a research note on Monday, October 23rd. BTIG Research assumed coverage on Waters in a research note on Friday, January 5th. They set a “buy” rating and a $230.00 target price on the stock. Morgan Stanley raised Waters from an “underweight” rating to an “equal weight” rating and set a $192.00 target price on the stock in a research note on Monday, December 4th. Barclays lifted their target price on Waters from $188.00 to $193.00 and gave the company an “equal weight” rating in a research note on Wednesday, October 25th. Finally, Goldman Sachs Group assumed coverage on Waters in a research note on Tuesday, September 26th. They set a “hold” rating and a $180.00 target price on the stock. Eleven equities research analysts have rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company. Waters currently has a consensus rating of “Hold” and an average price target of $197.33.

ILLEGAL ACTIVITY WARNING: This piece of content was posted by Ticker Report and is owned by of Ticker Report. If you are reading this piece of content on another site, it was illegally stolen and republished in violation of United States & international copyright and trademark laws. The legal version of this piece of content can be read at https://www.tickerreport.com/banking-finance/3142866/marathon-asset-management-llp-has-113-67-million-stake-in-waters-co-wat.html.

About Waters

Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WAT).

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


© 2006-2018 Ticker Report. Google+.